Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.
The Association of American Medical Colleges has added and refined questions about mistreatment in medical education to its Graduation Questionnaire, increasing the amount and specificity of information about what kinds of incidents occur and how students feel about them.